auranofin gold salt classified world health organization antirheumatic agent brand name ridaura auranofin used treat rheumatoid arthritis improves arthritis symptoms including painful tender swollen joints morning auranofin safer treatment compared common injectable gold thiolates gold sodium thiomalate gold thioglucose metaanalysis clinical trials concluded somewhat less drug approved treatment rheumatoid arthritis longer firstline treatment rheumatoid arthritis due adverse effects associated longterm use chronic disease common adverse effects gastrointestinal complaints loose stools abdominal cramping watery diarrhea develop early months treatment development loose stools occurs patients watery diarrhea reported patients cases symptoms alleviated reducing splitting auranofin investigation means reducing viral reservoir hiv lies latent bodys tcells despite treatment antiretroviral drug shown reduce amount latent virus monkey human study testing auranofin investigational treatments ongoing preliminary results show auranofin contributed decrease viral auranofin identified highthroughput drug screen times potent metronidazole entamoeba histolytica protozoan agent human amebiasis assays thioredoxin reductase transcriptional profiling suggest effect auranofin enzyme enhances sensitivity trophozoites reactive oxygenmediated killing mouse hamster models results marked reductions number parasites inflammatory reaction infestation damage auranofin may useful prevention control acanthamoeba infections treatment primary amoebic meningoencephalitis caused pathogenic freeliving amoebae acanthamoeba spp naegleria fowleri cellbased screen auranofin showed potent activity replicating nonreplicating tuberculosis well grampositive bacteria auranofin protected mice otherwise lethal infection methicillinresistant aureus mrsa drug acts similar manner bacteria parasites inhibiting thioredoxin reductase trxr studies humans needed evaluate potential drug treat grampositive bacterial infections drugscreening reveals auranofin induces apoptosis ovarian cancer cells mice protein kinase cι kp adenocarcinoma tumors exhibited resistance antibody therapy treated auranofin pkcι inhibitor auranofin inhibited kp tumor growth sensitized tumors mayo clinic running clinical trial research effects auranofin sirolimus squamous ras mutated lung adenocarcinoma small cell lung cancer auranofin may inhibit replication virus responsible causing cell culture inflammation may also brand name ridaura coined phrase remissioninducing drug auranofin httpsenwikipediaorgwikiauranofin